Improvements for Multiple Sclerosis Patients in Study Published in Annals 20/08/2007 06:00:00 Business Wire US12328X1072 TYSABRI is a treatment approved for relapsing forms of MS in the United States and relapsing-remitting MS in the European Union.
From: www.infobolsa.es
For more detailed information on the risks and uncertainties
Posted by Ruslan Abuzant at 12:32 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment